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Abstract
Gestational hypertension may confer risk of atopic disease in offspring through a direct biological mechanism, but another
possibility is that risk is mediated through complications of pregnancy. To explore these associations, we conducted an analysis
of a nationally representative birth cohort based in the UK involving children born 2000–2002.We included 12,450mother-child
pairs. We used logistic regression to estimate the association between hypertensive disease and asthma, hay fever, or eczema by
age 5, and parentally reported early wheeze and severe wheeze. Mediation by gestation at delivery and caesarean delivery was
explored using causal mediation analysis. Odds ratios (95% CI) for gestational hypertension and childhood asthma, hay fever,
and eczema were 1.32 (1.09, 1.59), 1.22 (0.97, 1.55), and 1.12 (0.96, 1.32) respectively, adjusted for confounding. The popu-
lation attributable fractions were 2.4% (1.0–3.8%), 0.9% (−0.3% to 2.1%), and 1.8% (0.0–3.7%), respectively. Accounting for
mediation by gestational age and caesarean delivery, odds ratios (95% CI) for the potential direct effects of gestational hyper-
tension were 1.21 (0.97, 1.50), 1.17 (0.91, 1.49), and 1.11 (0.94, 1.31) for the same.
Conclusion: Gestational hypertension was weakly positively associated with asthma and this was partly mediated by earlier
delivery. Only a small proportion of early childhood asthma was attributable to gestational hypertensive disease in this repre-
sentative UK-based birth cohort.
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Introduction
Atopy describes the tendency to develop allergic diseases like
atopic eczema, asthma, hay fever, and food allergy, which
often occur in those with elevated immunoglobulin E (IgE)
levels. A simplified blueprint of atopy includes genetic pre-
disposition to epithelial barrier dysfunction, aberrant antigen
exposure, and atopic activation [1, 2]. Fillagrin gene muta-
tions, pattern receptor gene mutations, and cytokine-related
gene mutations have been implicated [1–4]. As our knowl-
edge of the genetic determinants of atopic disease has ad-
vanced, so has our knowledge that atopic disease encom-
passes an array of allergic phenotypes in which elevated IgE
What is known:
• Gestational hypertension has been shown to be an inconsistent risk factor for the atopic diseases.
• The in utero immune environment may modify the risk of atopy in offspring; alternatively, complications of pregnancy including caesarean delivery
and prematurity may explain an association between hypertensive disease and atopy.
What is new:
• Self-reported gestational hypertension was a weak risk factor for asthma and wheeze in the Millennium Cohort Study.
• Part of the association between gestational hypertensive disease and asthma was explained by earlier delivery.
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is a common component [2] and the notion of the “atopic
march” has been complicated [5, 6]. Environmental determi-
nants of specific atopic phenotypes may include in utero ex-
posures, particularly those leading to immune dysfunction.
Pregnancy-induced hypertension (PIH) is the new onset of
hypertension in pregnancy after 20 weeks of gestation. The
disease may progress to glomerular endotheliosis and in-
creased vascular permeability which produces the additional
characteristic proteinuria of pre-eclampsia (PET).
Dysregulation of communication at the maternal decidual
and fetal trophoblastic interface is recognized as an antecedent
of PET, which may reduce immune tolerance of the fetus [7]
and produce inflammation characterized by decreased regula-
tory T-cells and anti-inflammatory cytokines [8, 9], features of
both PET and atopic disease [10–13]. PETmay be a risk factor
for atopy in offspring; however, complications of pregnancy
as a result of PET, like earlier delivery or caesarean delivery,
may equally confer risk. Determining the direction and
strength of the association between gestational hypertensive
disease and individual atopic diseases may help to character-
ize the atopic phenotypes and inform pre-conception or ante-
natal prevention strategies.
Objective
The aim is to investigate the role of gestational hypertension in
the development of early childhood atopic disease and to char-
acterize this association further by considering the mediating
role of gestational age and caesarean delivery which may lie




The Millennium Cohort Study (MCS) is a UK-based lon-
gitudinal study of the socioeconomic circumstance,
growth, and development of children born 1 September
2000–31 August 2001 [14]. Data collection is ongoing
with the first three waves collected at approximately 9
months [15], 3 years [16], and 5 years of age [17]. The
sample frame incorporated children resident in the UK at
9 months of age whose parents were eligible to receive
childhood tax benefit. Although near-universal eligibility,
asylum seekers were ineligible for childhood tax benefit
[14] and undocumented households were also excluded.
The survey was clustered at the electoral ward level with
UK-wide coverage, and with oversampling of deprived and
more ethnically diverse wards such that on baseline sam-
pling at the first wave, 82% of cohort members were White,
2.5% Indian, 4.8% Pakistani, 2% Bangladeshi, 1.3% Black
Caribbean, and 2% Black African with the remaining 3%
of mixed ethnicity [14]. At wave 1, the achieved sample
was 18,552 families from an issued sample of 21,180; at
wave 2, 15,590 families were achieved from 19,244 issued
including 1389 new families not issued at wave 1; at wave
3, 15,246 families were achieved from 18,528 issued [14].
Included in the present analysis were mother-child pairs
with responses for the first three surveys, where baseline
survey was completed by the natural mother following a
singleton pregnancy and subsequent surveys by either nat-
ural parent. The study flow diagram for the current analysis
is shown in Fig. 1.
Fig. 1 Flow diagram of
participants according to
eligibility and exclusion criteria.
MCS 1-3, Millennium Cohort
Study survey waves 1–3
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Exposure
In the MCS, women were asked whether they experienced
“any illnesses or other problems during [their] pregnancy that
required medical attention or treatment?” If answered affirma-
tively, they were asked whether they suffered “raised blood
pressure, eclampsia/ pre-eclampsia or toxaemia” during preg-
nancy [18]. The exposure was gestational hypertension, de-
fined as a self-reported history of PIH or PET, which were
combined in the MCS wave 1 questionnaire.
Outcomes
Outcomes were parentally reported eczema, asthma, or hay
fever at the age 5 wave [18]. Secondary outcomes were pa-
rentally reported symptomatic outcomes of early wheeze
(wheeze under 3 years of age) and severe wheeze (≥4 attacks
of wheeze or ≥ 1 night of sleep disturbance secondary to
wheeze or wheeze that affects speech within the last 12
months at age 5), as defined by the International Study of
Asthma and Allergies in Childhood (ISAAC) criteria [19].
Potential confounders
Measured confounders considered included maternal
covariables of age at delivery (<25 years, 25–29 years, 30–
34 years, ≥35 years), ethnicity (Black, South Asian, White,
Other), highest educational attainment (no recognized level,
foundation diploma, higher diploma, advanced diploma, cer-
tificate of higher education, foundation degree, bachelor’s de-
gree, postgraduate degree), history of asthma (yes, no), hay
fever (yes, no), eczema (yes, no), parity (primiparous, multip-
arous), and smoking status during pregnancy (non-smoker,
<10 cigarettes, ≥10 cigarettes per day). Women were asked
about any longstanding illness, and diagnoses were grouped
by ICD-10 code [18]; adjustment was made for a history of
essential hypertension on report of essential hypertension by
ICD-10 code I10 (yes, no). Household covariables included
OECD equivalized household income quintile. Infant
covariables were birth weight adjusted for gestation and sex,
to account for sex differences and to avoid biasing estimates
for gestation due to collinearity. We also included infant sex,
which has been associated with atopy as well as gestational
hypertensive disease in a recent meta-analysis which included
several large population studies [20].
Potential mediators
Potential mediators considered were gestation at birth (days)
and caesarean delivery (vaginal, caesarean).
Statistical analysis
MCS surveyweights were used throughout the statistical anal-
ysis to account for both stratified cluster sampling and for non-
response attrition bias. Descriptively, unweighted counts and
weighted proportions of maternal and infant characteristics
were calculated according to exposure for categorical vari-
ables. Weighted medians and interquartile ranges were calcu-
lated for non-normally distributed continuous variables, and
weighted mean z-scores and 95% confidence intervals (CIs)
were calculated for birth weight adjusted for gestation and sex
using the Intergrowth calculator [21, 22]. The functional form
of continuous variables was examined. Odds ratios and 95%
CIs were calculated for each outcome using multiple logistic
regression with model selection according to literature review.
A partially adjusted model was adjusted for maternal age,
education and ethnicity, household income, maternal history
of atopic diseases, parity, smoking status during pregnancy,
essential hypertension, infant sex, and birth weight adjusted
for gestation and sex. Estimates are with reference to their
respective specific disease-free populations. A fully adjusted
model was additionally adjusted for gestational age and cae-
sarean delivery. Mediation by gestational age and caesarean
delivery was explored in causal mediation analysis. Causal
mediation analysis was completed using the third-party Stata
package ‘khb’ based on the method outlined by Breen et al.
[23]. The total, direct, and combined and individual indirect
effects of gestational age and caesarean delivery were calcu-
lated with adjustment for the above confounders. Population
attributable fractions were calculated using the Stata package
‘punaf’ based on the method outlined by Greenland and
Drescher [24] to estimate the proportion of cases of the pri-
mary outcomes secondary to gestational hypertension, under
the assumption of a causal relationship. All analyses were
completed using Stata version 16 (StataCorp, 2019). Tests
were considered significant at a two-tailed p-value <0.05.
Results
There were 13,235 mother-child pairs with responses at all
three survey waves. Of these, 175 were ineligible due to a
multiple pregnancy and 173 were ineligible due to response
from someone other than the natural mother at wave 1 or other
than a natural parent at waves 2 and 3. Subsequently, 12,887
mother-child pairs were eligible and of these, 129 were miss-
ing outcome data and 308 were missing data on any
covariable and were excluded. Data were missing for <1%
of all participants across all covariables except for parity,
which had missingness of 1.1%, leading to the exclusion of
3.4% of eligible participants in total. We therefore proceeded
to a complete case analysis of 12,450 mother-child pairs of
which 950 mothers (7.7%) had gestational hypertensive
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disease. Among offspring, 4242 (35%) suffered from eczema,
1857 (15%) asthma, and 1342 (10%) hay fever (weighted
proportions) whilst 3805 (31%) were symptomatic of early
wheeze and 924 (7.3%) severe wheeze. All outcomes were
commoner among offspring to women with gestational hyper-
tension, as shown in Table 1. Women with gestational hyper-
tension tended to have higher levels of education and
household income, and a greater proportion suffered from
maternal asthma, hay fever, or eczema. The caesarean rates
were higher and median gestational age lower for women with
gestational hypertension. Unadjusted, there was strong evi-
dence that gestational hypertension was positively associated
with early wheeze (OR 1.34 [95% CI 1.14–1.58], p=0.001),
asthma (OR 1.35 [95% CI 1.12–1.62], p=0.002), hay fever
Table 1 Baseline characteristics
of study participants Characteristic Total PIH/PET Non-PIH/PET
(n = 12,450) (n = 950) (n = 11,500)
Maternal characteristics
Age, n. (%)
<25 years 2926 (22) 219 (21) 2707 (23)
25–29 years 3486 (29) 303 (34) 3183 (28)
30–34 years 3905 (32) 271 (29) 3634 (32)
≥ 35 years 2133 (18) 157 (17) 1976 (18)
Ethnicity, n. (%)
White 10,836 (90) 854 (92) 9982 (90)
South Asian 1089 (6.3) 55 (4.0) 1034 (6.5)
Black 339 (2.4) 28 (2.8) 311 (2.4)
Other 186 (1.3) 13 (1.3) 173 (1.3)
Household income quintile, n. (%)
1 2556 (18) 170 (15) 2386 (19)
2 2646 (19) 175 (16) 2471 (20)
3 2457 (20) 200 (22) 2257 (20)
4 2475 (21) 220 (25) 2255 (21)
5 2316 (21) 185 (22) 2131 (21)
Education by NVQ, n. (%)
None 1912 (14) 105 (11) 1807 (14)
1 979 (8.0) 56 (5.0) 923 (8.3)
2 3604 (30) 305 (33) 3299 (30)
3 1833 (14) 159(16) 1674 (14)
4 3661 (31) 300 (32) 3361 (30)
5 461 (3.7) 25 (2.1) 436 (3.8)
Maternal asthma, n. (%) 2058 (17) 193 (21) 1865 (17)
Maternal hay fever, n. (%) 3046 (26) 271(28) 2775 (25)
Maternal eczema, n. (%) 2186 (19) 208 (24) 1978 (18)
Multiparity, n. (%) 7142 (57) 419 (43) 6723 (58)
Caesarean, n. (%) 2682 (21) 349 (36) 2333 (20)
Infant characteristics
Male sex, n. (%) 6343 (51) 488 (53) 5855 (51)
Gestation, median weeks (IQR) 40.0 (2.1) 39.0 (2.0) 40.0 (2.0)
Birth weight z-score, mean (SE) 0.33 (0.01) 0.20 (0.04) 0.34 (0.01)
Eczema, n. (%) 4242 (35) 358 (39) 3884 (35)
Asthma, n. (%) 1857 (15) 169 (18) 1688 (14)
Hay fever, n. (%) 1342 (10) 122 (13) 1220 (10)
PIH pregnancy-induced hypertension, PET preeclampsia, NVQ National Vocational Qualification level, IQR
interquartile range, SE standard error
Maternal and infant characteristics according to exposure. Counts are unweighted; proportions, means, and
medians are weighted according to MCS wave 3 survey weights
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(OR 1.36 [95% CI 1.08–1.71], p=0.008), and eczema (OR
1.19 [95% CI 1.02–1.40], p=0.03), and there was weaker ev-
idence of an association with severe wheeze (OR 1.31 [95%
CI 0.99–1.72], p=0.06). After adjustment for confounding by
maternal age, education, ethnicity, income, maternal atopic
diseases, parity, smoking status, essential hypertension, infant
sex, and birth weight adjusted for gestation and sex, the point
estimates for the associations for early wheeze (OR 1.31
[1.10–1.56], p=0.002), severe wheeze (OR 1.29 [0.98–1.72],
p=0.07), and asthma (OR 1.32 [1.09–1.59], p=0.004) were
slightly attenuated. After adjustment, there was weak evidence
for the association with hay fever (OR 1.22 [95% CI 0.97–
1.55], p=0.09), and eczema (OR 1.12 [95% CI 0.96–1.32],
p=0.1). Inclusion of birth weight adjusted for gestation and
sex did not alter the estimates for gestational hypertension and
was not a significant inclusion in any of the models below a p-
value of 0.15. After additional adjustment for gestational age
and caesarean delivery, there remained evidence of an associ-
ation with early wheeze (OR 1.22 [95% CI 1.02–1.45],
p=0.03) and asthma (OR 1.20 [95% CI 1.00–1.45], p=0.06),
although attenuated, but not severe wheeze (OR 1.18 [95% CI
0.89–1.58], p=0.3). The full results are shown in Table 2.
Population attributable fractions for the total effects of gesta-
tional hypertension, calculated from the partially adjusted
models, were 2.4% (1.0–3.8%), 0.9% (−0.3% to 2.1%), and
1.8% (0.0 to 3.7%) for asthma, eczema, and hay fever,
respectively.
Causal mediation
There was evidence that the association between gestational
hypertensive disease and asthma was mediated by gestational
age. The estimated total (potential) effect for asthma was com-
parable to that obtained from the main model after adjustment
for potential confounding: OR 1.32 (1.06–1.63, p=0.012). The
estimated direct effect was OR 1.21 (0.97–1.50, p=0.089), in
this case comparable to the main model after adjustment for
these potential mediators. The estimated indirect effect of
gestational age was OR 1.08 (1.05–1.12), with 28% of the
association mediated by gestational age. There was no evi-
dence of mediation by gestational age for hay fever or eczema,
nor by caesarean delivery for asthma, hay fever, or eczema.
The estimated combined indirect, individual indirect, and the
direct effects are shown in Table 3.
Discussion
After adjustment for confounding, there was strong evidence
that gestational hypertension was a risk factor for early
wheeze and asthma, and weak evidence that it was a risk
factor for severe wheeze and hay fever. The effect sizes were
weak, with gestational hypertension increasing the odds of
early wheeze, severe wheeze, and asthma by approximately
a third, and hay fever by a fifth. These partially adjusted
Table 2 Odds ratios for primary










Early wheeze 3805 1.34 (1.14, 1.58) 1.31(1.10, 1.56) 1.22 (1.02, 1.45)
Severe wheeze 924 1.31 (0.99, 1.72) 1.29 (0.98, 1.72) 1.18 (0.89, 1.58)
Asthma 1857 1.35 (1.12, 1.62) 1.32 (1.09, 1.59) 1.20 (1.00, 1.45)
Hay fever 1342 1.36 (1.08, 1.71) 1.22 (0.97, 1.55) 1.17 (0.92, 1.48)
Eczema 4242 1.19 (1.02, 1.40) 1.12 (0.96, 1.32) 1.11 (0.95, 1.31)
OR odds ratio, CI confidence internal
1 Adjusted for potential confounding bymaternal age, education and ethnicity, household income, maternal atopy,
parity, smoking status in pregnancy, essential hypertension, infant sex, and birth adjusted for gestation and sex
2Additionally adjusted for potential mediation by caesarean delivery and gestational age
Table 3 Adjusted odds ratios for the decomposed effects of gestational







Total effect1 1.32 (1.06, 1.63) 1.22 (0.96, 1.56) 1.12 (0.95, 1.32)
Direct effect1 1.21 (0.97, 1.50) 1.17 (0.91, 1.49) 1.11 (0.94, 1.31)
Indirect effect1 1.09 (1.05, 1.13) 1.05 (1.01, 1.09) 1.01 (0.98, 1.03)
Caesarean2 1.01 (0.99, 1.03) 1.02 (0.99, 1.05) 1.01 (0.99, 1.02)
Indirect effect, % 4.7 12 7.1
Gestational age3 1.08 (1.05, 1.12) 1.02 (0.99, 1.04) 1.00 (0.98, 1.02)
Indirect effect, % 28 12 1.0
aOR adjusted odds ratio, CI confidence interval
1 Total, direct, and indirect effects for both caesarean and gestational age
combined, adjusted for maternal age, education and ethnicity, household
income, maternal atopic diseases, parity, essential hypertension, smoking
status in pregnancy, infant sex, weight by gestational age
2 Indirect effect of caesarean
3 Indirect effect of lower gestational age
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findings are relevant because they encompass the potential
distal effects of gestational hypertension, including the effects
of the timing and mode of delivery. The fraction of cases
attributable to this total potential effect of gestational hyper-
tension was minimal. The observed associations were attenu-
ated after further adjustment for potential mediation by cae-
sarean and gestational age. In the formal mediation analysis,
28% of the effect of gestational hypertension was mediated by
gestational age, with earlier delivery conferring risk of asthma.
The estimated total effect of gestational hypertension in the
mediation analysis remained consistent and was weak, and the
strength of the evidence for a direct effect of gestational hy-
pertension on asthma was weaker.
The main strengths of this analysis were its sample size,
consideration of a comprehensive range of confounders in-
cluding socioeconomic, maternal health, and pregnancy relat-
ed sources of confounding, the inclusion of formal mediation
analysis and data linking perinatal events and health at age 5.
Due to the representativity of the MCS population, the find-
ings are generalizable to a UK population. The main limitation
of this study was its use of self-reported exposures and out-
comes which may introduce recall bias by under or over-
estimating the true disease prevalence. One Canadian valida-
tion study found parental report of physician-diagnosed asth-
ma to be highly specific but not sensitive [25], and two vali-
dation studies in UK-based cohorts found parental report of
physician-diagnosed asthma sensitive and specific compared
with GP clinical record of asthma [26, 27]. It is conceivable
that parent report of ever having had asthma may be more
sensitive but less specific compared with parental report of
physician-diagnosed asthma; however, parental report of
“having ever had” asthma has shown good agreement with
clinical assessment (sensitivity 0.96 and specificity 0.87), the
gold standard diagnosis in a Norwegian validation study of
801 children [28]. Additionally, the prevalence of ever asthma
in the present study is comparable with that in the English arm
of the Mechanisms of the Development of Allergy
(MeDALL) cohort which used parental report of physician-
diagnosed asthma [29]. The ISAAC questionnaires have also
been broadly validated with good sensitivity and specificity
[30, 31]. To provide further insight, the symptomatic out-
comes supplement the main outcomes with information on
recent symptomatic status, “severe wheeze”, and to compare
with those who had early wheeze, “early wheeze” with which
we also observed strong evidence of an association.
Nevertheless, the potential for misclassification varies with
the different asthma definitions across population studies.
There is mixed evidence on the reliability of self-reported data
on gestational hypertension. One Norwegian study on histor-
ical pregnancies found self-report to be reliable even among
elderly women [32]. In another Danish study, the question
“did you have preeclampsia in pregnancy?” had sensitivity
73%, specificity 99%, but a positive predictive value of
59%, and “did you have hypertension in pregnancy?” 85%,
92%, and only 39% respectively, when compared with review
of the medical record [33] reflecting a tendency to report dis-
ease not truly present. Whilst it is not possible to interpret the
effect of the specific mode and wording of theMCS interview,
here women were only asked about specific medical problems
if they independently recognized a medical problem in the
first instance [18]. We theorize that this two-step question
may reduce the proportion of women who self-reported ges-
tational hypertensive disease who did not have true disease.
Nevertheless, there are likely to be some women who per-
ceived themselves to be hypertensive, potentially following
investigation for hypertension and who reported hypertensive
disease but who did not have true disease. We believe it to be
unlikely that a differential misclassification may have oc-
curred according to atopic disease outcome. Nevertheless,
our findings are limited by the use of self-reported data and
this misclassification introduced the potential for bias towards
the null. Similarly, identifying subtypes of hypertensive dis-
ease was not possible. A related limitation was the lack of IgE
assay to determine atopic sensitization biochemically which
would have enabled more precise classification into atopic or
non-atopic disease.
We observed a comparable association between gestational
hypertension and early wheeze, severe wheeze, and asthma
between the models. The consistency of the association across
wheeze types and asthma diagnosis reflects a well-described
association [34], and whilst the relationship between gesta-
tional hypertension and wheeze up to 2 years has been
established [35], the majority of these children do not develop
asthma. Early wheeze may signify a viral infective trigger for
later asthma or else may be a marker of susceptibility to asth-
ma [34] whilst severe wheeze at age 5 reflects recent and
uncontrolled symptoms to provide an alternative construction
of asthma. The consistency in the attenuation across these
overlapping populations is likely reflective of the related un-
derlying airway disease. However, the risk posed by gesta-
tional hypertension appears inconsistent across the different
atopic diseases; its differing associations with asthma and ec-
zema in the partially adjusted models as well as the different
patterns of potential mediation suggest heterogenous atopic
phenotypes. The association of gestational hypertension with
asthma and hay fever is congruent with previous findings of
an association with asthma and hay fever [36], asthma [37],
but also asthma, eczema, hay fever, and food allergy [38]. In
the latter registry-based cohort, a dose-dependent association
was observed for asthma and hay fever, and only an associa-
tion between preeclampsia greater than 14 days of duration
and eczema [38]. One birth cohort observed no association
between gestational hypertension and asthma, although did
observe an association with early wheeze and reduced lung
function at 8 years [39]. The less consistent findings between
atopic diseases in the present study may represent our
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adjustment for a wider range of confounders but potentially
also our use of self-reported and combined PIH and PET.
We considered both the independent effects of gestational
age and caesarean in the fully adjusted models, and potential
mediation in the mediation analysis. After adjustment for both
gestational age and caesarean delivery in the fully adjusted
model, there remained evidence of an association between
gestational hypertensive disease and asthma. There was only
weak evidence to support a direct effect of gestational hyper-
tension on asthma after considering possible mediation by
gestational age and caesarean delivery. It would appear that
a proportion of the potential effect on asthma is mediated by
earlier delivery. There remains weak evidence of a weak effect
exerted independently; equally, residual confounding may ac-
count for this association. One large registry-based cohort that
investigated the relationship between preeclampsia and asth-
ma using formal mediation analysis also found evidence of
mediation by gestational age [40]. We have not identified any
other formal mediation analyses relating to mode of delivery,
nor relating to the outcomes of eczema or hay fever. Whilst it
is likely that earlier delivery is a marker of severity of hyper-
tensive disease, prematurity is a recognized risk factor for
asthma including in contexts of preterm delivery not related
to gestational hypertension [41, 42]. We did not find evidence
that gestational hypertension was a risk factor for eczema nor
that risk of eczema is mediated in either direction by gesta-
tional age or caesarean. This is consistent with findings that
prematurity confers risk of asthma but not eczema, or atopic
dermatitis, in previous studies [43–45]. The risk of asthma
may be modified by efforts to manage risk factors for PIH
and PET prior to conception, risk factors for preterm birth
more broadly, and prophylactic treatment for PET prevention
with aspirin.
Potential mechanisms from gestational hypertension and
atopic diseases include the immune dysregulation of pre-
eclampsia which may lead to upregulation of placental
pro-inflammatory mediators and suppression of anti-
inflammatory mediators implicated in atopic disease in off-
spring [8, 46, 47]. T-helper population imbalance has been
found to associate with greater eosinophilia and allergen
sensitization [48, 49]. However, complications of gestation-
al hypertension also increase the risk of early delivery [40,
42] and delivery by caesarean section [50, 51]. Preterm in-
fants may be more susceptible to asthma due to physical or
immunological lung immaturity, and respiratory secretions
of preterm infants have been found to contain pro-
inflammatory compounds [52]. Caesarean delivery may al-
ter exposure to skin commensals of the delivering infant
which may affect gut microbial composition and therefore
immunomodulatory effects of the gut microbiome [53], but
we did not find evidence to support the relevance of this
pathway in the context of gestational hypertension accord-
ing to these individual clinical diagnoses. It is difficult to
determine whether the observed associations may be due to
an in utero effect of pre-eclampsia due to an altered immune
environment or whether we may be observing the effects of
prematurity. Either way, gestational hypertension was not a
strong risk factor for any of the atopic diseases studied.
Additionally, we cannot exclude the possibility that the
weak association between gestational hypertensive disease
and asthma after accounting for mediation is due to residual
confounding. Gestational hypertension may be a weak risk
factor and a determinant of pregnancy complications which
are themselves complex and inter-related; however, within
the MCS, we did not observe a significant direct potential
effect on the independent clinical entities of asthma, hay
fever, or eczema, nor for early wheeze or severe wheeze.
If a mechanistic pathway did exist between gestational hy-
pertension and these outcomes, then it accounts only for a
minority of cases among women with gestational hyperten-
sion. From a public health perspective, the moderate
strength of what is an uncommon risk factor means that
gestational hypertension, including its distal effects on
timing and mode of delivery, is not a major determinant of
these diseases as a whole and this was reflected in the small
population attributable fractions. We studied these out-
comes as individual diagnoses, and it remains possible that
gestational hypertension may be a risk factor for specific
subtypes of atopic disease.
The decision for delivery in pregnancy complicated by hy-
pertensive disease in general involves balance between reduc-
ing maternal morbidity by early delivery and leaving the fetus
in utero to prevent the sequelae of preterm birth including
respiratory distress syndrome [54]. The obstetrician therefore
faces a difficult dilemma when deciding when to deliver a
woman with PIH. Substantial respiratory morbidity has been
reported in offspring and adults born at 32–36 weeks of age
[55], a gestational interval in which obstetricians often con-
sider early delivery for pre-eclampsia. Whilst the risk of child-
hood asthma is not a consideration when managing the imme-
diate risk hypertensive disease poses to fetus and mother,
characterization of the relationship between gestational hyper-
tension and atopic disease and the possible mediating role of
earlier delivery provides further insight into the longer-term
health of this group of infants.
Conclusion
We observed a weak association between gestational hyper-
tensive disease and offspring asthma, with part of this rela-
tionship mediated by earlier delivery but not by mode of de-
livery. This study indicates the need to characterize the likely
distinct aetiologies of atopic phenotypes further to identify
any subtypes of disease with risk factors amenable to modifi-
cation at the very start of the life course.
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